» Articles » PMID: 8137938

Both Interleukin-8 Receptors Independently Mediate Chemotaxis. Jurkat Cells Transfected with IL-8R1 or IL-8R2 Migrate in Response to IL-8, GRO Alpha and NAP-2

Overview
Journal FEBS Lett
Specialty Biochemistry
Date 1994 Mar 21
PMID 8137938
Citations 37
Authors
Affiliations
Soon will be listed here.
Abstract

Neutrophil leukocytes, the target cells for interleukin-8 and related CXC chemokines, bear high numbers of two types of IL-8 receptors (IL-8R1 and IL-8R2). By cDNA transfection Jurkat cell lines were generated that stably express either IL-8R1 or IL-8R2 (J-IL8R1 and J-IL8R2). J-IL8R1 expressed 4,000 +/- 1,000 copies of IL-8R1, and bound IL-8 with high affinity (Kd 1-4 nM) and GRO alpha and NAP-2 with low affinity (Kd 200-500 nM). J-IL8R2 expressed 17,000 +/- 3,000 copies of IL-8R2, and bound all three chemokines with high affinity. Both transfectants showed a similar degree of chemotactic migration after stimulation with IL-8, GRO alpha and NAP-2. All three chemokines were equally potent as attractants of J-IL8R2, whereas IL-8 was 300 to 1,000-fold more potent than GRO alpha or NAP-2 as attractant of J-IL8R1. The potencies, therefore, agree with the affinities of the ligands to IL-8R1 and IL-8R2. Our results demonstrate that both IL-8 receptors function independently, and mediate chemotaxis in response to IL-8 and other CXC chemokines.

Citing Articles

Adverse effects of CXCR2 deficiency in mice reared under non-gnotobiotic conditions.

Garcia M, Morales M, Yang T, Holden J, Bossardet O, Palmer S Sci Rep. 2024; 14(1):26159.

PMID: 39478033 PMC: 11525579. DOI: 10.1038/s41598-024-75532-9.


The Clinical Significance and Involvement in Molecular Cancer Processes of Chemokine CXCL1 in Selected Tumors.

Korbecki J, Bosiacki M, Szatkowska I, Kupnicka P, Chlubek D, Baranowska-Bosiacka I Int J Mol Sci. 2024; 25(8).

PMID: 38673949 PMC: 11050300. DOI: 10.3390/ijms25084365.


The Role of CXCR1, CXCR2, CXCR3, CXCR5, and CXCR6 Ligands in Molecular Cancer Processes and Clinical Aspects of Acute Myeloid Leukemia (AML).

Korbecki J, Kupnicka P, Barczak K, Bosiacki M, Zietek P, Chlubek D Cancers (Basel). 2023; 15(18).

PMID: 37760523 PMC: 10526350. DOI: 10.3390/cancers15184555.


Bioinformatic Analysis of the CXCR2 Ligands in Cancer Processes.

Korbecki J, Bosiacki M, Chlubek D, Baranowska-Bosiacka I Int J Mol Sci. 2023; 24(17).

PMID: 37686093 PMC: 10487711. DOI: 10.3390/ijms241713287.


Heterodimers Are an Integral Component of Chemokine Signaling Repertoire.

Kaffashi K, Dreau D, Nesmelova I Int J Mol Sci. 2023; 24(14).

PMID: 37511398 PMC: 10380872. DOI: 10.3390/ijms241411639.